Karne Kingston, who now works as a pharmaceutical marketing expert and biotech analyst, has publicized information proving that Pfizer knows its vaccine makes the likelihood of infection with COVID-19 much higher.
To prove this, Kingston has presented a briefing document used by the Food and Drug Administration (FDA) during an advisory committee meeting on Sept. 17. The meeting was held to discuss Pfizer's application to use its COVID-19 vaccine as a booster.
The documents presented during the meeting include a report on a study conducted by Pfizer that tested how long its vaccines provide so-called immunity to the coronavirus. (Related: Pfizer CEO says US to return to normal within a year but only if everybody takes COVID-19 vaccines.)
The study involved over 36,000 participants who were injected with the vaccine. It found that the group of people that received the vaccines at an earlier time were significantly more likely to get infected by the coronavirus than those who received the boosters at a later date.
The group that got the vaccine earlier had a seven percent chance of infection during the study period. The group that got the booster at a later date had a 5.16 percent chance of infection. Meaning, the former has a 36 percent greater chance of infection than the latter.
But Kingston points out that the study has a flaw. The latter group has had a significant period before they got the vaccine when their chances of getting infected were much smaller. Pfizer has not expounded on this part of the study. "There should have been more people infected in the placebo group because they were going on longer without any protection," says Kingston.
The study's conclusion is that "incidence of COVID-19 generally increased in each group of study participants with increasing time post-Dose 2."
"If you have two doses of Pfizer, your rate for getting infected increases over time," explains Kingston.
Kingston has looked at the rate of infection in the placebo group for the first four months of the study, when they had no vaccine-acquired "protection" against COVID-19. She has then compared it with the group's rate of infection in the four months following their injections with Pfizer's vaccines.
"So, when they weren't injected, their infection rate was 1.3 percent, and when they got injected, it was 4.34 percent. It went up by over 300 percent," says Kingston. "They had less infection when they had no protection. So, that's a problem."
Pfizer's COVID-19 vaccines becoming more available all over the world
Despite the clear evidence proving that Pfizer's vaccine makes it more dangerous for people to live, the company's COVID-19 vaccines are still spreading.
In the United States, Pfizer's COVID-19 vaccines are now being distributed by the government as boosters for the fully vaccinated. Currently, people 65 years old and older and adults who work or live in high-risk settings and have underlying medical conditions are eligible to get booster doses. There are plans in place to expand this to allow more people to get Pfizer's boosters.
The FDA's Vaccines and Related Biological Products Advisory Committee is also expected to hold a meeting in late October to review data submitted by Pfizer. This data supposedly proves that the vaccine is safe to give to children between the ages of five and 11.
Learn more about the dangers of taking Pfizer's COVID-19 vaccine by reading the latest articles at Vaccines.news.
Sources include:
Please contact us for more information.
